Eagle Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$151M Sell
1,468,962
-3,368
-0.2% -$400K 0.77% 32
2024
Q2
$188M Buy
1,472,330
+27,197
+2% +$3.5M 1.01% 10
2024
Q1
$189M Sell
1,445,133
-174,657
-11% -$21.5M 0.96% 15
2023
Q4
$177M Sell
1,619,790
-46,127
-3% -$4.79M 0.95% 12
2023
Q3
$172M Sell
1,665,917
-76,713
-4% -$8.27M 1.02% 9
2023
Q2
$201M Sell
1,742,630
-36,208
-2% -$4.11M 1.12% 6
2023
Q1
$189M Buy
1,778,838
+45,360
+3% +$4.9M 1.11% 9
2022
Q4
$193M Buy
1,733,478
+9,138
+0.5% +$934K 1.18% 7
2022
Q3
$149M Buy
1,724,340
+346,694
+25% +$30.9M 0.97% 17
2022
Q2
$126M Sell
1,377,646
-313,569
-19% -$27.8M 0.79% 25
2022
Q1
$139M Sell
1,691,215
-124,984
-7% -$9.85M 0.71% 37
2021
Q4
$140M Buy
1,816,199
+92,031
+5% +$7.33M 0.61% 51
2021
Q3
$130M Buy
1,724,168
+14,535
+0.9% +$1.11M 0.58% 49
2021
Q2
$133M Sell
1,709,633
-113,528
-6% -$8.44M 0.57% 52
2021
Q1
$134M Buy
1,823,161
+1,332,086
+271% +$98.3M 0.59% 39
2020
Q4
$38.3M Sell
491,075
-1,377,703
-74% -$105M 0.22% 163
2020
Q3
$146M Buy
1,868,778
+376,872
+25% +$29.5M 0.75% 23
2020
Q2
$108M Sell
1,491,906
-273,063
-15% -$20.6M 0.62% 44
2020
Q1
$130M Buy
1,764,969
+2,165
+0.1% +$170K 0.81% 17
2019
Q4
$153M Buy
1,762,804
+24,538
+1% +$2.02M 0.74% 21
2019
Q3
$140M Sell
1,738,266
-193,121
-10% -$15.5M 0.72% 22
2019
Q2
$155M Buy
1,931,387
+83,654
+5% +$6.41M 0.79% 14
2019
Q1
$147M Buy
1,847,733
+130,981
+8% +$9.8M 0.78% 12
2018
Q4
$125M Buy
1,716,752
+19,588
+1% +$1.38M 0.79% 12
2018
Q3
$115M Sell
1,697,164
-20,357
-1% -$1.3M 0.56% 34
2018
Q2
$99.5M Sell
1,717,521
-178,832
-9% -$10.1M 0.54% 46
2018
Q1
$98.6M Sell
1,896,353
-2,366
-0.1% -$128K 0.54% 46
2017
Q4
$101M Buy
1,898,719
+821,641
+76% +$45.6M 0.55% 41
2017
Q3
$66.3M Buy
1,077,078
+3,397
+0.3% +$206K 0.38% 81
2017
Q2
$65.7M Sell
1,073,681
-616,546
-36% -$37.5M 0.4% 73
2017
Q1
$102M Sell
1,690,227
-38,939
-2% -$2.36M 0.64% 34
2016
Q4
$97.1M Buy
1,729,166
+59,653
+4% +$3.49M 0.64% 34
2016
Q3
$99.4M Buy
1,669,513
+55,635
+3% +$3.25M 0.67% 23
2016
Q2
$88.7M Buy
1,613,878
+68,375
+4% +$3.64M 0.61% 27
2016
Q1
$78M Buy
1,545,503
+43,246
+3% +$2.12M 0.54% 36
2015
Q4
$75.7M Buy
1,502,257
+6,279
+0.4% +$317K 0.51% 46
2015
Q3
$70.5M Buy
1,495,978
+12,706
+0.9% +$675K 0.48% 52
2015
Q2
$80.6M Buy
1,483,272
+57,931
+4% +$3.25M 0.45% 67
2015
Q1
$78.2M Buy
1,425,341
+237,631
+20% +$13.5M 0.45% 68
2014
Q4
$64.4M Sell
1,187,710
-253,835
-18% -$14.1M 0.37% 92
2014
Q3
$81.5M Buy
1,441,545
+76,723
+6% +$4.31M 0.47% 66
2014
Q2
$75.3M Sell
1,364,822
-89,021
-6% -$4.86M 0.41% 80
2014
Q1
$78.8M Buy
1,453,843
+47,259
+3% +$2.45M 0.43% 56
2013
Q4
$67.4M Sell
1,406,584
-4,115,382
-75% -$188M 0.38% 75
2013
Q3
$252M Buy
5,521,966
+4,204,465
+319% +$192M 1.25% 3
2013
Q2
$58.4M Buy
+1,317,501
New +$58.8M 0.39% 68

Other funds holding MRK

Eagle Asset Management's MRK Position: Q3 2024 in Review

Eagle Asset Management reduced its Merck (MRK) stake by 0.23% in Q3 2024, selling an estimated $400K and leaving 1,468,962 shares worth $151M. The position accounts for 0.77% of the portfolio, ranked #32.

Eagle Asset Management first reported a position in MRK in Q2 2013 and has held it in 46 quarters since. The position peaked at $252M in Q3 2013. 3,489 funds tracked by Wall St. Rank hold MRK as of Q3 2024.

  • Eagle Asset Management held 1,468,962 shares of Merck worth $151M as of Q3 2024.
  • Eagle Asset Management sold 3,368 Merck shares in Q3 2024, an estimated $400K.
  • Merck made up 0.77% of Eagle Asset Management's portfolio in Q3 2024, its #32 holding.
  • Eagle Asset Management first reported a position in Merck in Q2 2013 and has held it in 46 quarters since.
  • Eagle Asset Management's Merck position peaked at $252M in Q3 2013.
  • 3,489 funds tracked by Wall St. Rank held Merck as of Q3 2024.

Based on Eagle Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.